Hemant Malhotra MBBS, MD, FRCP (London), FRCP(Edinburgh) FACP (USA), MNAMS, FICP, FUICC, FIMSA

Dr. Hemant Malhotra is presently a Professor of Medicine at the SMS Medical College Hospital & Head of the division of Medical Oncology at the Birla Cancer Center. The SMS Medical College Hospital is a 2000 bedded hospital, one of the leading teaching and patient care center in North India. Dr. Malhotra graduated and post-graduated at the top of his batch from the SMS Medical College and after fellowships from Tata Memorial Cancer Center, Mumbai; Cornell Medical Center, New York, and Memorial Sloan Kettering Cancer Center, New York, set up the Medical Oncology division in the Department of Medicine at the SMS Hospital in 1991, the first in the state of Rajasthan. Very recently, he has set up a Bone Marrow Transplantation Unit at the SMS and his team has successfully done the first-ever autologous bone marrow transplantation in the state of Rajasthan.

He is an internationally and nationally recognized medical oncologist and was the India, Pakistan & Bangladesh representative to the European Society for Medical Oncology (ESMO) from 2006 to 2008. He is also ESMO board certified in medical oncology. He is an advisor/consultant/referee/committee member for oncology to several Government of India bodies and heads the ICMR committee for formulation of guidelines for multiple myeloma. He is one of the members of the sub-committee of the ICMR which has developed and published Indian guidelines for the treatment of CML. He is the Leukemia Lymphoma disease committee head of the Indian Cooperative Oncology Network (ICON). He has been an invited consultant to the WHO on guideline development for bio-similar oncology molecules.

Dr. Malhotra has to his credit more than 200 international and national publications and presentations and is an office bearer and member of many international and national societies and organizations. He is the Principal Investigator for many International & National clinical trials and is on the Data Safety & Monitoring Board (DSMB) for two new oncology molecules. He is the present honorary secretary of the Indian Society of Medical & Pediatric Oncology (ISMPO).